NBIX: Neurocrine Biosciences Inc

Новости NBIX

• Investing 12:36 Neurocrine reports quality of life gains for older adults using INGREZZA
• Seeking Alpha 14:10 PGIM Jennison Health Sciences Fund Q1 2025 Commentary (PHLAX)
• Investing 20:13 Neurocrine Biosciences names new Chief Information Officer
• Investing 11:04 Guggenheim maintains buy rating on Neurocrine Bio stock amid growth prospects
• Investing 13:01 Oppenheimer initiates Axsome Therapeutics stock with outperform rating
• Investing 13:04 Neurocrine Biosciences Presents Patient-Reported Outcomes from KINECT-PRO™ Study Demonstrating INGREZZA ® (valbenazine) Capsules Improved Functionality and Quality of Life in Patients with Tardive D
• Investing 11:50 RBC Capital maintains outperform rating for Neurocrine Bio stock
• Investing 20:33 Fate Therapeutics appoints new board member
• Seeking Alpha 15:35 abrdn Healthcare Opportunities Fund Q1 2025 Commentary
• Investing 13:37 Voyager Therapeutics stock plunges to 52-week low of $2.71
• Investing 22:17 Neurocrine Biosciences director sells shares worth $1.16 million
• Investing 20:12 Neurocrine reports positive Phase 2 schizophrenia study results
• Investing 14:34 Stifel maintains $166 target on Neurocrine Bio shares
• Investing 17:15 Neurocrine at RBC Conference: Growth and Strategic Insights
• Investing 12:36 Neurocrine reports lasting benefits of CRENESSITY in CAH study
• Investing 12:32 Neurocrine reports quality of life gains in tardive dyskinesia study
• Investing 21:20 Neurocrine Biosciences Presents Data on Improvements in Physiologic Glucocorticoid Dosing and Select Reproductive Hormones in Patients with Classic Congenital Adrenal Hyperplasia Taking CRENESSITY™
• Investing 21:08 Neurocrine Biosciences Presents Findings Contributing to the Growing Body of Evidence on the Impact of High-Dose Glucocorticoids on Clinical Outcomes in Congenital Adrenal Hyperplasia
• Investor's Business Daily 14:42 Stock Market Indexes In Range But Leaders Flash Buy Signals Amid Trump Trade Deal: Weekly Review
• Investor's Business Daily 17:58 Stock Market Today: Dow Jones, S&P 500 Losses Climb; These Two New Issues Jump While Palantir Tanks (Live Coverage)
• Benzinga 17:24 Neurocrine Biosciences' Ingrezza Q1 Sales Prove Resilient, Analysts Boost Price Target - Neurocrine Biosciences (NASDAQ:NBIX)
• Investor's Business Daily 15:24 Neurocrine Biosciences Surges On 'Surprising' Momentum For Its Newest Drug
• Benzinga 14:02 FARO Technologies, Celanese, Avient, Aramark And Other Big Stocks Moving Higher On Tuesday - Aramark (NYSE:ARMK), Ameresco (NYSE:AMRC)
• Investing 20:36 Neurocrine Biosciences stock soars on strong INGREZZA guidance